Abstract
Oral mucositis is common, painful, dose-limiting toxicity of drug and radiation therapy for cancer. In granulocytopenic patients, the ulcerations which accompany mucositis are frequent portals of entry for indigenous oral bacteria often leading to bacteremias or sepsis. The complexity of mucositis as a biological process has only recently been appreciated. The condition appears to represent a sequential interaction of the oral mucosal cells and tissues, pro-inflammatory cytokines, and local environmental factors in the mouth such as microorganisms and saliva. The recognition that the pathophysiology of mucositis is a multifactorial process has presented opportunities for intervention based on biological attenuation. Interleukin-11, a pleotropic cytokine, has a range of activities which is potentially relevant to mucositis. Consequently, it has been used successfully to modify the development, severity and course of mucositis in an animal model which closely mimics the equivalent human condition.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sonis, S., Edwards, L. & Lucey, C. The biological basis for the attenuation of mucositis: the example of interleukin-11. Leukemia 13, 831–834 (1999). https://doi.org/10.1038/sj.leu.2401441
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401441
Keywords
This article is cited by
-
Experiences of patients who developed oral mucositis during solid neoplasms treatment: a Ugandan qualitative study
Journal of Patient-Reported Outcomes (2021)
-
Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients
Supportive Care in Cancer (2014)
-
Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model
Bone Marrow Transplantation (2006)
-
Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies
Supportive Care in Cancer (2006)
-
A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation
Bone Marrow Transplantation (2003)